Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

FDA Approvals: Promius Pharma's Sernivo approved in US as topical steroid - Dr. Reddy\'s Laboratories

Dr. Reddy's Laboratories

Uploaded: 2021

Dr. Reddy’s Q1FY26 Financial Results

24 Jul 2025

// PRESS RELEASE

Dr Reddy's Plan to Launch Generic of Novo's Weight-Loss Drug

24 Jul 2025

// REUTERS

Dr Reddys’ Generics Eribulin Mesylate Receives Approval

03 Jul 2025

// FDA

DATA COMPILATION
#PharmaFlow

DRL VB RM

Contact Supplier

CPhI Korea

Attending

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

https://www.pharmacompass.com/video-pharmareel/dr-reddys-laboratories/leading-supplier-of-apis-for-40-years

Xls

CATEGORY PAGE

Dr. Reddy's Laboratories

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2025, Corporate Presentation, API Product List 2025, Products Under Development 2025, FDF Product List 2024, GMP Certificate 2024

Product List 2025
Corporate Presentation
API Product List 2025
Products Under Development 2025
FDF Product List 2024
GMP Certificate 2024

VIDEO(s)

Leading Supplier of APIs for 40+ Years, Your Partner for High-Quality & Cost-effective APIs, Dr. Reddy's - About Us

Leading Supplier of APIs for 40+ Years
Your Partner for High-Quality & Cost-effective APIs
Dr. Reddy's - About Us

DIGITAL CONTENT

2 Vlog #PharmaReel, 9 Corporate Content #SupplierSpotlight, 10 Data Compilation #PharmaFlow, 1104 News #PharmaBuzz

2 Vlog #PharmaReel
9 Corporate Content #SupplierSpotlight
10 Data Compilation #PharmaFlow
1104 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

291 All APIs, 154 USDMF, 44 CEP/COS, 33 JDMF, 154 EU WC, 148 KDMF, 114 NDC API, 146 Listed APIs

291 All APIs
154 USDMF
44 CEP/COS
33 JDMF
154 EU WC
148 KDMF
114 NDC API
146 Listed APIs

DEVELOPMENTS

107 Drugs in Development

107 Drugs in Development

FINISHED DOSAGE FORMULATIONS

800 FDF Dossiers, 567 FDA Orange Book, 10 Europe, 223 Listed Dossiers

800 FDF Dossiers
567 FDA Orange Book
10 Europe
223 Listed Dossiers

KEY PRODUCTS

Apixaban, Capecitabine, Carfilzomib, Dabigatran Etexilate Mesylate, Dapagliflozin, Dapagliflozin Propanediol Monohydrate, Empagliflozin, Enzalutamide, Eribulin, Ferric Carboxymaltose, Glatiramer Acetate, Iron Sucrose, Mirabegron, Nilotinib, Olaparib, Palbociclib, Quetiapine Hemifumarate, Rivaroxaban, Sacubitril-Valsartan, Sitagliptin Hydrochloride, Sitagliptin Malate, Sitagliptin Phosphate, Sugammadex Sodium

Apixaban
Capecitabine
Carfilzomib
Dabigatran Etexilate Mesylate
Dapagliflozin
Dapagliflozin Propanediol Monohydrate
Empagliflozin
Enzalutamide
Eribulin
Ferric Carboxymaltose
Glatiramer Acetate
Iron Sucrose
Mirabegron
Nilotinib
Olaparib
Palbociclib
Quetiapine Hemifumarate
Rivaroxaban
Sacubitril-Valsartan
Sitagliptin Hydrochloride
Sitagliptin Malate
Sitagliptin Phosphate
Sugammadex Sodium

EXCIPIENTS

1 All Excipients, 1 USDMF

1 All Excipients
1 USDMF

INSPECTIONS & REGISTRATIONS

66 FDA, 37 EDQM, 18 GDUFA

66 FDA
37 EDQM
18 GDUFA

PC100302

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!